AnalystsMartin FanMartin Fan's Stock Forecasts
AnalystsMartin Fan
Sectors:
Industries:
Analyst Ranking
Top 28%
#1403 out of 5087 analysts
Average Return
+43.51%
Win Rate
80%8 out of 10
Risk vs Reward
Poor
Good
Martin Fan's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Oruka Therapeutics IncORKA | +197.78% | $9.46 | $28.17 | 2025-05-14 - 2025-10-31 | Buy |
Anaptysbio IncANAB | +79.58% | $20.37 | $36.58 | 2025-08-06 - 2025-10-31 | Buy |
Aclaris Therapeutics IncACRS | +78.72% | $1.41 | $2.52 | 2025-05-27 - 2025-10-31 | Buy |
Anaptysbio IncANAB | +68.57% | $21.70 | $36.58 | 2025-04-30 - 2025-10-31 | Buy |
Sana Biotechnology IncSANA | +45.16% | $3.41 | $4.95 | 2025-09-23 - 2025-10-31 | Buy |
Martin Fan Analyst Color
Get additional color on Martin Fan's coverage of popular stocks
Martin Fan's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Artiva Biotherapeutics IncARTV | 2 | Buy | $23.00 | +451.56% | Maintains | 17 days ago |
Zenas Biopharma IncZBIO | 1 | Buy | $40.00 | +28.00% | Maintains | 25 days ago |
Anaptysbio IncANAB | 3 | Buy | $45.00 | +23.02% | Reiterates | a month ago |
Sana Biotechnology IncSANA | 1 | Buy | $5.00 | +1.01% | Initiates Coverage On | a month ago |
Cartesian Therapeutics IncRNAC | 1 | Buy | $38.00 | +365.12% | Initiates Coverage On | 4 months ago |
Aclaris Therapeutics IncACRS | 1 | Buy | $8.00 | +217.46% | Initiates Coverage On | 5 months ago |
Oruka Therapeutics IncORKA | 1 | Buy | $40.00 | +42.00% | Reiterates | 6 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.